MEDICAMENTS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20100137201A1
SERIAL NO

12306501

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

There is provided the use of WNT5A, or a therapeutically effective fragment or derivative thereof, in the preparation of a medicament for use in the prevention, reduction or inhibition of scarring. There is also provided the use of WNT5A, or a therapeutically effective fragment or derivative thereof, in the preparation of a medicament for use in the prevention and/or treatment of a fibrotic disorder. Further aspects relate to methods by which scarring may be prevented, reduced or inhibited, and by which fibrotic disorders may be prevented and/or treated. Therapeutically effective amounts of WNT5A, or its fragments or derivatives, that may be used in the medicaments or methods of the invention are also provided.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
RENOVO LIMITEDMANCHESTER

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ferguson, Mark W J Manchester, GB 15 154
Goldspink, Nicholas Manchester, GB 4 3
Laverty, Hugh G Manchester, GB 1 1
Nield, Kerry Manchester, GB 11 34
O'Kane, Sharon Manchester, GB 32 103
Occleston, Nicholas Machester, GB 14 15

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation